Back to JPMORGAN CHASE & CO JPMORGAN CHASE & CO

TPSTTPST
2 quarters

Position history for JPMORGAN CHASE & COJPMORGAN CHASE & CO's holdings in TEMPEST THERAPEUTICS INC

No. JPMorgan Chase exited its TPST (Tempest Therapeutics) position in Q2 2026. Its Q1 2026 13F listed 5 shares worth $8. JPMorgan Chase first reported TPST in Q1 2026 and held it in 1 quarterly 13F filing.

Final Value

$0

Final Shares

0

Total Value Change

-$8

Total Shares Change

-5

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Exited
0
-100.0%
$00.0%$1.11
0
2026-Q1
New
5
-
$80.0%$1.64
17

Other major holders of TPST: VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used